Fig. 1From: A randomized controlled trial comparing the effects of dapagliflozin and DPP-4 inhibitors on glucose variability and metabolic parameters in patients with type 2 diabetes mellitus on insulinAverage glucose profiles during treatment with dapagliflozin and DPP-4 inhibitors. The black solid line and grey solid lines show the mean and SD at baseline, respectively. The black dotted line and grey dotted lines show the mean and SD at the end of the study, respectivelyBack to article page